Company Overview
About Zoetis
Zoetis Inc. is the world's largest animal health company, developing, manufacturing, and commercializing medicines, vaccines, diagnostics, and other technologies for companion animals (dogs, cats, horses) and livestock (cattle, swine, poultry, fish). Spun off from Pfizer in 2013, Zoetis has maintained its position as the global leader in animal health with approximately 300 product lines serving veterinarians, livestock producers, and pet owners in over 100 countries.
Business Model & Competitive Advantage
Zoetis reported approximately $9.1 billion in revenue in FY2024, with companion animals representing roughly 55% of revenue and growing faster than the livestock segment. The shift toward companion animals reflects a powerful cultural and demographic trend: pet ownership is increasing globally, pets are increasingly viewed as family members, and spending per pet is rising as veterinary capabilities advance and pet insurance adoption grows. Zoetis's blockbuster portfolio includes Apoquel and Cytopoint (atopic dermatitis treatments for dogs), Simparica Trio (parasite protection), and Librela/Solensia (monoclonal antibodies for osteoarthritis pain in dogs and cats).
Competitive Landscape 2025–2026
The monoclonal antibody franchise represents Zoetis's most significant innovation: Librela (bedinvetmab) is the first approved monoclonal antibody for pain management in dogs with osteoarthritis, addressing an enormous unmet need in companion animals. These biologics are protected by complex manufacturing processes and intellectual property, creating durable competitive advantages. The livestock segment provides steady cash flows from parasiticides, antibiotics, and vaccines, while the companion animal segment drives premium growth through innovative specialty products.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
Zoetis is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $9100M in revenue, Zoetis operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare Zoetis with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Zoetis? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Zoetis Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Zoetis vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →